To receive news and publication updates, enter your email address in
the box below
Sorafenib combination with imatinib enhances apoptotic and cell cycle arrest effects with no effect on viability and BCR-ABL expression of K-562 cells
Belal A. Al-Husein, Ahmad Al-Azayzih, Fatema S. Redha
DOI: 10.7324/JAPS.2024.161424Pages: